NUAGE THERAPEUTICS

LOGO NUAGE THERAPEUTICS

Contact information

Nuage Therapeutics S.L.
Andri Leonidou - Head of BI and Corporate Affairs
Parc Científic de Barcelona (PCB), Tower I, Baldiri Reixac 10-12
Barcelona - 08208
Barcelona
+34 934 031 370
Areas of activities
  • Drug development
  • Drug discovery
  • Oncology

Nuage Therapeutics is redefining drug discovery for intrinsically disordered proteins. Our mission is to usher in a new wave of transformational therapies for aggressive cancers with limited treatment options. By pioneering a novel drug discovery approach, we directly target the oncogenic transcription factors that drive cancer progression, shutting down key disease pathways that have remained beyond the reach of conventional drug discovery. This ground-breaking approach could revolutionize the way that certain tumor types are treated.

Our strategy is rooted in causal human biology—focusing only on targets where function is unequivocally linked to disease. Oncology is just the start. We believe that our technology can be leveraged to address difficult to drug proteins in a range of other therapeutic areas. 
 

Products and services

Drug Discovery for Intrinsically Disorderes Proteins, with a focus on transcription factors.

Areas of interest for future collaborations

Drug Discovery, oncology, transcription factors, intrinsically disordered proteins.